Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
Recruiting · NCT06842524 · Registry updated 2025-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome | Adnexal Diseases, Cysts, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endocrine system disorder, female reproductive system disorder, gonadal disorder, neoplasm, ovarian cyst, ovarian disorder, polycystic ovary syndrome | Recruiting | Phase 2 | 2025-04-20 | NCT06842524 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Zhongshan Hospital | 347 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Wenzhou Medical University | Wenzhou | China | 87 |
| The First Affiliated hospital of Xiamen University | Xiamen | China | 69 |
| Women and Children's Hospital, School of Medicine, Xiamen University | Xiamen | China | 1 |
| Zhongshan Hospital Fudan University | Shanghai | China | 38 |